WOUNDCHEK™ Laboratories Appoints ApoFit As Exclusive Distributor For WOUNDCHEK™ Protease Status In Germany

GARGRAVE, England--(BUSINESS WIRE)--WOUNDCHEK™ Laboratories announced today that it has appointed ApoFit Arzneimittelvertrieb GmbH as exclusive distributor in Germany for the world’s first point of care diagnostic for chronic wound care, WOUNDCHEK™ Protease Status. This partnership is aimed at achieving increased focus on the commercialisation of this innovative wound diagnostic product in the German market.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC